88th General Assembly · Funnel one-pager · Monday, November 9, 2026
SF 2342: Relating to insurance coverage for diagnostic breast cancer examinations, and including applicability provisions
Died when the session ended · The General Assembly adjourned on June 14, 2020. Bills that didn’t pass both chambers died.
Sponsors
Not listed
Cost
Cost: up to $129,000
The fiscal impact of SF 2342 for shifting the share of costs associated with diagnostic breast cancer examinations from Plan members to the Plan is approximately $122,000 in FY 2021 and $129,000 in FY 2022. 1% of the total amount paid by the State of Iowa Plan…
Lobbying · 2 for, 0 against
For: Genentech, Inc., A Member of the Roche Group; Iowa Army of Pink
In plain words
- February 20, 2020Filed in the Senate
- February 20, 2020Approved by the Senate committee
- February 27, 2020Cost estimate (fiscal note) posted
From public records at legis.iowa.gov, compiled by Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Monday, November 9, 2026. https://iowafunnel.com/bills/88/SF2342